These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18759307)

  • 1. Treatment-failure gout: a moving target.
    Edwards NL
    Arthritis Rheum; 2008 Sep; 58(9):2587-90. PubMed ID: 18759307
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment failure gout.
    Ali S; Lally EV
    Med Health R I; 2009 Nov; 92(11):369-71. PubMed ID: 19999896
    [No Abstract]   [Full Text] [Related]  

  • 3. Alternative treatment for chronic gout could relieve pain for thousands. The recently approved intravenous drug, pegloticase, may work when other treatments don't.
    Duke Med Health News; 2013 Jan; 19(1):3. PubMed ID: 23762971
    [No Abstract]   [Full Text] [Related]  

  • 4. Pegloticase and the patient with treatment-failure gout.
    Dave AJ; Kelly VM; Krishnan E
    Expert Rev Clin Pharmacol; 2012 Sep; 5(5):501-8. PubMed ID: 23121270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of gout.
    Meltzler M
    BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24493155
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical inquiry: Which prophylactic therapies best prevent gout attacks?
    White S; Mounsey A; Tillett J
    J Fam Pract; 2014 Apr; 63(4):216, 221. PubMed ID: 24905127
    [No Abstract]   [Full Text] [Related]  

  • 7. Debulking the urate load to feel better.
    Richette P
    J Rheumatol; 2012 Jul; 39(7):1311-3. PubMed ID: 22753797
    [No Abstract]   [Full Text] [Related]  

  • 8. Update on emerging urate-lowering therapies.
    Chohan S; Becker MA
    Curr Opin Rheumatol; 2009 Mar; 21(2):143-9. PubMed ID: 19339925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of massive tophaceous gout with three urate-lowering drugs.
    Mejía-Chew C; Torres RJ; de Miguel E; Puig JG
    Am J Med; 2013 Nov; 126(11):e9-10. PubMed ID: 23978312
    [No Abstract]   [Full Text] [Related]  

  • 10. Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.
    Biggers K; Scheinfeld N
    Curr Opin Investig Drugs; 2008 Apr; 9(4):422-9. PubMed ID: 18393109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gout: an overview of available urate lowering therapies].
    Richette P
    Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of chronic refractory tophaceous gout with erosions with pegloticase.
    Yeter KC; Ortiz EC; Arkfeld DG
    Int J Rheum Dis; 2013 Jun; 16(3):369-70. PubMed ID: 23981765
    [No Abstract]   [Full Text] [Related]  

  • 13. Trends in Utilization of Urate-Lowering Therapies Following the US Food and Drug Administration's Boxed Warning on Febuxostat.
    Kim SC; Neogi T; Kim E; Lii J; Desai RJ
    Arthritis Rheumatol; 2021 Mar; 73(3):542-543. PubMed ID: 33029931
    [No Abstract]   [Full Text] [Related]  

  • 14. Uricase and other novel agents for the management of patients with treatment-failure gout.
    Sundy JS; Hershfield MS
    Curr Rheumatol Rep; 2007 Jun; 9(3):258-64. PubMed ID: 17531181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A challenging case of gout and failure of anti-TNF therapy- are current treatments adequate?
    Nisar MK; Baburaj K
    Int J Rheum Dis; 2011 Aug; 14(3):e42-3. PubMed ID: 21816013
    [No Abstract]   [Full Text] [Related]  

  • 16. Crystal arthritis. Intensive urate-lowering therapy improves structural joint damage in patients with tophaceous gout.
    Buckland J
    Nat Rev Rheumatol; 2013 Sep; 9(9):506. PubMed ID: 23897441
    [No Abstract]   [Full Text] [Related]  

  • 17. [Using the whole arsenal to prevent an attack].
    Füeßl HS; Stiefelhagen P
    MMW Fortschr Med; 2015 Nov; 157(20):22. PubMed ID: 26977497
    [No Abstract]   [Full Text] [Related]  

  • 18. Pegloticase for treating refractory chronic gout.
    George RL; Sundy JS
    Drugs Today (Barc); 2012 Jul; 48(7):441-9. PubMed ID: 22844655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advances in gout: pathogenesis, diagnosis, comorbidities, treatment].
    Soós B; Szamosi S; Benkő S; Paragh G; Szekanecz Z
    Orv Hetil; 2018 Oct; 159(40):1625-1636. PubMed ID: 30277413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New therapeutic options for gout].
    Richette P; Ottaviani S; Bardin T
    Presse Med; 2011 Sep; 40(9 Pt 1):844-9. PubMed ID: 21684104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.